SALT LAKE CITY, March 8, 2022 – Varex Imaging Corporation (Nasdaq: VREX) announced today that it is scheduled to present at Oppenheimer’s 32nd Annual Healthcare virtual investor conference.
Details are as follows:
Oppenheimer’s 32nd Annual Healthcare Conference
Varex will be presenting on Tuesday, March 15, 2022 at 2:40 pm ET.
The listen-only webcast link is: https://wsw.com/webcast/oppenheimer20/vrex/2821014
The company’s Chief Financial Officer, Sam Maheshwari, will provide an overview of Varex’s business. Varex’s presentation will be webcast and accessible to the public via the company’s website at vareximaging.com. Replays will be available for 90 days after the presentation at the same website.
Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that
are key components of X-ray imaging systems. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate Varex’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose, protect and inspect.
Headquartered in Salt Lake City, Utah, Varex employs approximately 2,100 people located in North America, Europe, and Asia. For more information visit vareximaging.com.
Forward Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements
using the terms “believe,” “expect,” “intend,” “future,” “anticipate,” “will,” “could,” or similar statements are forward-looking statements that involve risks and uncertainties that could cause
Varex’s actual results to differ materially from those anticipated. While forward-looking statements are based on assumptions and analyses made by us that we believe to be reasonable under the
circumstances, whether actual results and developments will meet our expectations and predictions depend on a number of risks and uncertainties which could cause our actual results,
performance, and financial condition to differ materially from our expectations. Such risks and uncertainties include global political and economic conditions, events, and hostilities; Varex’s ability to maintain compliance with our financial covenants; the continued impact of tariffs or a global trade war on Varex’s products and customer purchasing patterns; demand for and delays in delivery of products of Varex or its customers; Varex’s ability to develop, commercialize and deploy new products; the impact of reduced or limited demand by purchasers of certain X-ray products; the impact of competitive products and pricing; and the other risks listed from time to time in our filings with the U.S. Securities and Exchange Commission, which by this reference are incorporated herein. Any forward-looking statements made by us speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. Varex assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.
For Information Contact:
Director of Investor Relations
Varex Imaging Corporation
801.973.1566 | email@example.com
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2022.
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2022 following the close of regular trading on Tuesday, May 3, 2022.
Varex Imaging Corporation will attend the 34th annual Control international trade fair in Stuttgart, Germany
Varex Imaging Corporation today announced the partial redemption of $27 million of its 7.875% senior secured notes due 2027, which represents 10% of the outstanding principal amount of the notes.
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2022.
SALT LAKE CITY, July 1, 2021 – Varex Imaging Corporation (Nasdaq: VREX) today announced the partial redemption in the amount of $30 million of its $300 million 7.875% senior secured notes due 2027, in accordance with the terms and conditions of the governing indenture
Varex Imaging Corporation today announced its unaudited financial results for the fourth quarter of fiscal year 2021.
Phoenix Convention Center for ASNT 2021 - November 15-18
Varex Imaging Corporation today announced its unaudited financial results for the third quarter of fiscal year 2021.
Varex Imaging Announces LUMEN 4336W Radiography Detector With IP68 Rating
Varex Imaging Announces Partial Redemption of Senior Secured Notes.
The new LUMEN 4336W has been designed with reliability in mind from the start. By simplifying the construction of the internal components, we have minimized potential points of failure while also improving the design of the housing to provide added protection from external shocks.
SALT LAKE CITY, May 4, 2021 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2021.
Varex Imaging Schedules Second Quarter FY2021 Earnings Release and Conference Call
SALT LAKE CITY, February 4, 2021 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2021.